Literature DB >> 34119837

Direct detection of intracellular miRNA in living circulating tumor cells by tumor targeting nanoprobe in peripheral blood.

Chang Xu1, Xiao-Yan He2, Xiao-He Ren1, Si-Xue Cheng3.   

Abstract

Molecular analysis of circulating tumor cells (CTCs) is of critical significance for the non-invasive early detection of tumors. However, in situ detection of intracellular nucleic acids of CTCs in whole blood still remains challenge. By using a highly efficient tumor targeting nanoprobe, we realize in situ detection of microRNA-21 (miR-21) of living CTCs in unprocessed whole blood. In the nanoprobe, a catalytic hairpin assembly (CHA) system is complexed with protamine sulfate (PS), and then decorated by SYL3C conjugated hyaluronic acid (SHA) and hyaluronic acid (HA). The CHA system can be specifically delivered into living CTCs in whole blood, followed by hybridization between the CHA system and intracellular miR-21 in CTCs to induce strong fluorescence emission. After isolation of CTCs by membrane filtration, CTCs of cancer patients can be directly visualized by a fluorescence microscope for miR-21 detection at a single-cell level. Our study provides an efficient strategy to realize in situ genomic analysis of living CTCs in whole blood.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Circulating tumor cells; In situ detection; Nanoprobes; Tumor targeting

Year:  2021        PMID: 34119837     DOI: 10.1016/j.bios.2021.113401

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  3 in total

1.  Programming a DNA tetrahedral nanomachine as an integrative tool for intracellular microRNA biosensing and stimulus-unlocked target regulation.

Authors:  Lianyu Yu; Sha Yang; Zeyu Liu; Xiaopei Qiu; Xiaoqi Tang; Shuang Zhao; Hanqing Xu; Mingxuan Gao; Jing Bao; Ligai Zhang; Dan Luo; Kai Chang; Ming Chen
Journal:  Mater Today Bio       Date:  2022-05-06

2.  Functional Tumor Targeting Nano-Systems for Reprogramming Circulating Tumor Cells with In Situ Evaluation on Therapeutic Efficiency at the Single-Cell Level.

Authors:  Xiao-He Ren; Xiao-Yan He; Chang Xu; Di Han; Si-Xue Cheng
Journal:  Adv Sci (Weinh)       Date:  2022-05-20       Impact factor: 17.521

3.  Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment.

Authors:  Chiara Fischer; Andrey Turchinovich; Manuel Feisst; Fabian Riedel; Kathrin Haßdenteufel; Philipp Scharli; Andreas D Hartkopf; Sara Y Brucker; Laura Michel; Barbara Burwinkel; Andreas Schneeweiss; Markus Wallwiener; Thomas M Deutsch
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.